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Predicting nosocomial lower 
respiratory tract infections by a risk 
index based system
Yong Chen  1, Xue Shan2, Jingya Zhao1, Xuelin Han1, Shuguang Tian1, Fangyan Chen1, 
Xueting Su1, Yansong Sun1, Liuyu Huang1, Hajo Grundmann3,4, Hongyuan Wang2 & Li Han1
Although belonging to one of the most common type of nosocomial infection, there was currently 
no simple prediction model for lower respiratory tract infections (LRTIs). This study aims to develop a 
risk index based system for predicting nosocomial LRTIs based on data from a large point-prevalence 
survey. Among the 49328 patients included, the prevalence of nosocomial LRTIs was 1.70% (95% 
confidence interval [CI], 1.64% to 1.76%). The areas under the receiver operating characteristic (ROC) 
curve for logistic regression and fisher discriminant analysis were 0.907 (95% CI, 0.897 to 0.917) and 
0.902 (95% CI, 0.892 to 0.912), respectively. The constructed risk index based system also displayed 
excellent discrimination (area under the ROC curve: 0.905 [95% CI, 0.895 to 0.915]) to identify LRTI 
in internal validation. Six risk levels were generated according to the risk score distribution of study 
population, ranging from 0 to 5, the corresponding prevalence of nosocomial LRTIs were 0.00%, 0.39%, 
3.86%, 12.38%, 28.79% and 44.83%, respectively. The sensitivity and specificity of prediction were 
0.87 and 0.79, respectively, when the best cut-off point of risk score was set to 14. Our study suggested 
that this newly constructed risk index based system might be applied to boost more rational infection 
control programs in clinical settings.
Healthcare associated infection (HAI) represents a major public health problem from all around the world1–3. 
Patients with HAI might have prolonged hospital stays, and have high morbidity and mortality, thus adding eco-
nomic burden on the healthcare system4. Pneumonia and other lower respiratory tract infections (LRTIs) were 
the most common type of HAIs1,5. According to a large multicenter epidemiological survey from China, 8,739 
(59.55%) of 14,674 HAIs cases belonged to LRTI6.
It has been suggested that risk prediction model may have applications in identifying high-risk patients and 
evaluating the effectiveness of infection control measures7–9. Currently, some studies have identified the risk fac-
tors of nosocomial LRTIs, which include tracheal intubation, underlying chronic lung disease, supine body posi-
tion, mechanical ventilation, thoracic or upper abdominal surgery, prior episode of a large volume aspiration, 
and age older than 70 years10–12. However, these findings are difficult to be applied for risk prediction. Risk index 
based method is therefore needed in terms of its simplicity and feasibility in predicting the probability of acquir-
ing nosocomial LRTIs.
There are currently many risk index based systems in clinical field, such as acute physiology and chronic 
health evaluation II (APACHE II), therapeutic intervention scoring system (TISS) and simplified acute physiol-
ogy score (SAPS)13,14, however, these systems are not targeted for HAIs. Up to date, there are some studies trying 
to evaluate the application of risk index in predication of HAIs15 or surgical site infections (SSI)16, but no study 
focused on the predication of nosocomial LRTIs.
The purpose of this study was to develop a risk index based system for predicting nosocomial LRTIs using data 
from a large point-prevalence survey of HAIs, and to evaluate its sensitivity and specificity in identifying infection.
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Methods
Data source and study population. The data used in this study comes from a large one-day point-prev-
alence survey of HAIs between October 2014 and March 201517. All variables for each patient were extracted 
from the individual report form of this survey, including demographic data, days of hospitalization on survey 
date, invasive procedures, use of antibiotics and underlying diseases. Underlying diseases for each patient were 
transformed into ICD-10-CM three-character categories code and treated as a binary variable. The detailed 
information for these variables was shown in Supplemental Table S1. 49328 cases of patients from 46 hospitals 
with completed information for all variables were included in this study. This study was approved by institu-
tional review boards (IRB) of Academy of Military Medical Science. All methods were performed in accordance 
with the relevant guidelines and regulations. As all the data were analyzed anonymously, the IRB of Academy of 
Military Medical Science waived the informed consent requirement.
Case definition. The definition of nosocomial LRTIs was in accordance with diagnosis guideline issued by 
the National Health and Family Planning Commission of the People’s Republic of China (NHFPC; formerly the 
Chinese Ministry of Health) in 2001. Nosocomial LRTIs, which comprise of the CDC categories of ‘pneumonia’ 
and ‘lower respiratory tract infection other than pneumonia’, refer to infection acquired after 48 hours’ admission, 
unless there is a clear incubation period for the infection. Ventilator-associated pneumonia (VAP) was excluded 
for analysis in this study.
Logistic regression and fisher discriminant analysis. There’re several options for diagnostic and prog-
nostic tasks in clinical medicine, of which we chose multivariate logistic regression and fisher discriminant analy-
sis, both known as so-called white box models that allow an interpretation of model parameter18. For multivariate 
logistic regression, a backward selection algorithm was used, the coefficient (β) of the variables was estimated. The 
wald χ2 test was used to assess the covariate-adjusted p value. The p value for statistical testing of variable signifi-
cance for exclusion from model is set to 0.05. Candidate risk factor variables are listed in Supplemental Table S1. 
For fisher discriminant analysis, those variables statistically significant in logistic regression analysis were used as 
input factors, and whether or not an individual has nosocomial LRTI is the classification factor. The area under 
the receiver operating characteristic (ROC) curve was calculated for both predictive models.
Construction of risk index based system. The risk index based system was constructed by simplifying 
the parameters based on the logistic regression model with better ROC curve performance. A 10-fold cross vali-
dation scheme was applied to test the robustness of the logistic model. This means that we randomly divided the 
training data set into 10 partitions, applied the classification method 10 times to the data from 9 partitions, and 
used the respective 10th partition to test the performance. After this series of 10 classification tasks, we derived a 
ROC curve figure using the mean of each performance parameter.
If the difference between ROC curves of original logistic model and 10-fold cross validation is small, we can 
deem that logistic is a robust model. Then the risk index was derived based on the original logistic model. We 
firstly determined the smallest absolute value u of the coefficients, then divided all the parameters by u, and 
rounded the results to the nearest integer. To further simplify risk index system, approximate index values were 
adjusted to the same score. One patient’s total risk score is calculated through adding the scores of all risk items 
of the patient.
The prevalence of LRTIs was calculated for patients with different risk scores. Different risk levels were deter-
mined according to the total risk scores of each patient. The sensitivity and specificity of different risk scores were 
calculated for determining the best cut-off point. The performance of cut-off point in predicting LRTIs was also 
evaluated for patients with different underlying diseases. All the data were analyzed with SAS 9.4. All tests were 
considered as significant at p < 0.05.
Results
The prevalence of LRTIs. Among the 49328 patients included in this study, there were 839 cases of nosoco-
mial LRTIs, the overall prevalence was 1.70% (95% confidence interval [CI], 1.64% to 1.76%). The prevalence of 
nosocomial LRTIs among patients with different underlying diseases ranged from 0.2% to 50.0% (Supplemental 
Table S2). High prevalence was detected in patients with the following diseases: other respiratory disorders 
(17.3%), hydrocephalus (10.9%), nontraumatic intracerebral hemorrhage (10.3%), acute respiratory distress syn-
drome (7.1%), sequelae of cerebrovascular disease (5.9%), emphysema (5.8%), myeloid leukemia (5.5%) and lym-
phoid leukemia (5.3%). These diseases, which might jeopardize respiratory function, compromise the immune 
system or lead to patients’ prolonged stays in hospital, are considered to be significantly associated with the 
occurrence of LRTIs.
Prediction of LRTIs by logistic regression and fisher discriminant analysis. Logistic regression 
analysis showed that age, male, length of hospital stay, tracheotomy, artery or venous catheterization, urinary tract 
intubation are risk factors for nosocomial LRTIs. Prophylactic use of antibiotics can effectively reduce the risk of 
acquiring LRTIs. Judging from the estimated standardized regression coefficient, age has the strongest influence 
on whether a patient would acquire LRTI, for which the standardized coefficient is 0.36, followed by the length 
of hospital stay (0.31) and urinary tract intubation (0.22). Areas under the ROC curve for logistic regression and 
fisher discriminant analysis were 0.907 (95% CI, 0.897 to 0.917) and 0.902 (95% CI, 0.892 to 0.912), respectively. 
As shown in Fig. 1, there is little difference between the two statistical methods, especially for the curve on the 
upper left corner, where the best cut-off point most likely exists, suggesting that the predictive efficiency of the 
two models are almost the same.
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Prediction of LRTIs by risk index based system. As Fig. 2 reveals, the area under ROC curve was 
0.907 for internal validation, and 0.888 for 10-fold cross validation. The sensitivity and specificity of the best 
cut-off point that logistic regression internal validation can achieve was 0.86 and 0.79, respectively, and that 
of 10-fold cross validation is 0.87 and 0.74, respectively. The logistic model was stable, so we chose logistic 
regression coefficient to construct the risk index based system for predicting nosocomial LRTIs. The system 
includes ten categories of risk factors, each corresponds to a special risk score (Table 1). The overall risk 
score for each patient is the sum of the risk scores for all the potential risk factors of this patient (Table 1). 
The ROC curves of logistic regression and risk index scoring system are very similar (Fig. 3), indicating no 
significant loss of accuracy. The area under the ROC curve for the risk index system was 0.905 (95% CI, 
0.895 to 0.915). As risk score increases, the prevalence of LRTIs increases sharply (Fig. 4). For most of the 
patients, the total risk score represents the possibility of acquiring nosocomial LRTIs. Six risk levels were 
generated according to the total risk scores of all the study population, ranging from 0 to 5, the correspond-
ing prevalence of nosocomial LRTIs were 0.00%, 0.39%, 3.86%, 12.38%, 28.79% and 44.83%, respectively 
(Table 2).
All the potential cut-off points are shown in Table 3. Both the sensitivity and specificity were higher than 0.70, 
while the positive likelihood ratio and negative likelihood ratio varied from 3.50 to 7.20, and from 0.12 to 0.31, 
respectively. In practical application, one can choose the best cut-off point based on the specific task. In this study, 
we suggest 14 as the best cut-off point, for which the sensitivity and specificity were 0.87 and 0.79, respectively. 
To assess the predictive ability of 14, we calculated the sensitivity and specificity in subgroups with different diag-
nosis. The best cut-off point showed high discriminatory power in the majority of the subgroups with different 
underlying diseases, such as respiratory tuberculosis, malignant neoplasm of nasopharynx, malignant neoplasm 
of stomach, unspecified diabetes mellitus, et al. (Supplemental Table S3).
Figure 1. The ROC curves for predicting nosocomial lower respiratory tract infection derived from logistic 
regression and fisher discriminant analysis.
Figure 2. The ROC curves for predicting nosocomial lower respiratory tract infections derived from internal 
validation and external 10-fold cross validation scheme based on logistic regression model.
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Discussions
Predication of LRTIs among non-ventilated patients is very important for the early implementation of prevention 
strategies, including oral care, early mobilization interventions, swift diagnosis and treatment of dysphagia, as 
well as antimicrobial prophylaxis19,20. This study developed a risk index based system for LRTIs, which assigns 
a corresponding risk score to each patient according to the presence of risk factors, e.g. underlying diseases and 
Risk levels Risk score range No. of susceptible patients No. of LRTI cases Prevalence of LRTIs (%)
0 −7 to 4 3901 0 0.00%
1 5 to 15 36507 143 0.39%
2 16 to 20 6249 241 3.86%
3 21 to 25 2027 251 12.38%
4 26 to 30 528 152 28.79%
5 31 to 37 116 52 44.83%
total −7 to 37 49328 839 1.70
Table 2. The prevalence of lower respiratory tract infections among patients with different risk levels.
Cut-off 
values
No. of true 
positive cases
No. of false 
positive cases
No. of true 
negative cases
No. of false 





13 764 12791 35698 75 0.91 0.74 3.50 0.12
14 732 10284 38205 107 0.87 0.79 4.14 0.16
15 696 8224 40265 143 0.83 0.83 4.88 0.20
16 646 6589 41900 193 0.77 0.86 5.50 0.27
17 604 5056 43433 235 0.72 0.90 7.20 0.31
Table 3. The performance of predication for lower respiratory tract infections using different cut-off values.
Risk factor variables
Risk scores for each 
variable (points)
Presence of one of the following diseases: Enlarged prostate (N40), Malignant neoplasm of colon (C18) −8
Use of antibiotics for prophylactic purpose, Type IV incision operation −3
Type I incision operation, Age (5 points for patients of <4 years, 0 points for patients of 4–9 years, 1 points per 10 years 
for patients of ≥10 years) 1
Length of hospital stay (2 points per week until the total score reach 10 points), Mechanical ventilatory support 
in place, Presence of one of the following diseases: Cerebral infarction (I63), Intracranial injury (S06), Sequelae of 
cerebrovascular disease (I69)
2
Tracheotomy, Central or peripheral catheter in place, Male, Presence of one of the following diseases: Acute bronchitis 
(J20), Emphysema (J43), Encounter for follow-up examination after completed treatment for malignant neoplasm 
(Z08), Intracranial and intraspinal abscess and granuloma (G06), Malignant neoplasm of esophagus (C15), Malignant 
neoplasm of liver and intrahepatic bile ducts (C22), Other disorders of brain (G93), Other pleural conditions (J94), 
Other diseases of digestive system (K92), Secondary malignant neoplasm of respiratory and digestive organs (C78), 
Unspecified kidney failure (N19)
3
Urinary catheter in place, Presence of one of the following diseases: Acute pancreatitis (K85), Malignant neoplasm of 
bronchus and lung (C34), Malignant neoplasm of brain (C71), Malignant neoplasm without specification of site (C80), 
Nontraumatic intracerebral hemorrhage (I61), Other sepsis (A41), Other degenerative diseases of nervous system, not 
elsewhere classified (G31), Transplanted organ and tissue status (Z94)
4
Presence of one of the following diseases: Acute myocardial infarction (I21), Acute tonsillitis (J03), Complications 
and ill-defined descriptions of heart disease (I51), Hepatic failure, not elsewhere classified (K72), Intraoperative and 
postprocedural complications and disorders of digestive system, not elsewhere classified (K91), Other and unspecified 
types of non-Hodgkin lymphoma (C85), Other rheumatoid arthritis (M06), Pneumothorax and air leak (J93), 
Rheumatic mitral valve diseases (I05)
5
Presence of one of the following diseases: Acute nephritic syndrome (N00), Diaphragmatic hernia (K44), Esophageal 
varices (I85), Leukemia of unspecified cell type (C95), leukemias of specified cell type (C94), Lymphoid leukemia 
(C91), Myeloid leukemia (C92), Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs 
(D37), Open wound of head (S01), Other aplastic anaemias (D61), Other congenital malformations of circulatory 
system (Q28), Other Retention of urine (R33), Respiratory conditions due to other external agents (J70), Systemic 
lupus erythematosus (M32)
8
Presence of one of the following diseases: Arterial embolism and thrombosis (I74), Congenital pneumonia (P23), 
Malignant neoplasm of floor of mouth (C04), Other birth injuries (P15), Malignant neoplasm of other and unspecified 
female genital organs (C57), Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction (I66), 
Other disorders of cartilage (M94), Pain in throat and chest (R07), Toxic effect of pesticides (T60)
10
Presence of one of the following diseases: Excessive, frequent and irregular menstruation (N92), Other conditions 
originating in the perinatal period (P96), Other lack of coordination (R27), Other specified diseases with participation 
of lymphoreticular and reticulohistiocytic tissue (D76)
15
Table 1. The scoring system based on risk factors of nosocomial lower respiratory tract infections. The overall 
risk score for each patient is the sum of the scores for all the risk factor variables. The presence of underlying 
diseases was shown as disease type and its corresponding clinical modification (ICD-10-CM) code.
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medical treatment. The total scores derived from the risk factors of one patient would represent his/her risk for 
acquiring LRTI. Targeted prevention and control strategies could be implemented by healthcare workers accord-
ing to the results of risk evaluation, and the cost-effective of infection control programs in hospitals is expected 
to be improved.
In general, the discriminatory power of two statistical models and the risk index based system in predicting 
nosocomial LRTIs was excellent and comparable with previous studies9,15,21. The overall prevalence of LRTIs in 
this study was 1.7%, while for the patients with risk level at four and five, the prevalence were as high as around 
30% and 40%, respectively, which indicates that the system and the recommended best cut-off point could be used 
to identify patients with high risk. Active preventive measures could be taken for these patients19,22,23.
As the susceptibility of LRTIs among patients with different underlying diseases might be different, it is rea-
sonable that each patient’s underlying diseases should be treated as important risk factors and be included for 
constructing the risk index model. There was a fluctuation for the number of LRTI patients when the total risk 
score was above 30 (Fig. 3), which was possibly associated with the reduction of number of susceptible patients. 
For some patients with certain underlying diseases, the predicative effectiveness was suboptimal possibly due to 
lack of information on patients’ physiology status.
This study has some limitations. Firstly, no external validation was conducted in this study, the applicability 
of this risk predicative system in clinical field deserves further study; Secondly, the data of this study comes from 
a point-prevalence survey, no follow up was conducted for the study population, some patients, who acquired 
LRTI after the survey date, might be misclassified as non-LRTI cases; Thirdly, the missing of some risk factor data 
might affect the accuracy of model construction. However, the high sensitivity and specificity of the system in this 
study suggested that it might be applied to boost more rational and cost-effective infection control programs for 
nosocomial LRTIs.
Figure 4. The number of patients and prevalence of nosocomial lower respiratory tract infections among 
patients with different risk scores.
Figure 3. The ROC curves for predicting nosocomial lower respiratory tract infections derived from logistic 
regression and risk index based system.
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